Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kodiak Sciences (KOD) Liabilities and Shareholders Equity (2017 - 2026)

Kodiak Sciences filings provide 10 years of Liabilities and Shareholders Equity readings, the most recent being $306.0 million for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 2.72% to $306.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Mar 2026, down 19.56% year-over-year, with the annual reading at $351.5 million for FY2025, 4.75% up from the prior year.
  • Liabilities and Shareholders Equity hit $306.0 million in Q1 2026 for Kodiak Sciences, down from $351.5 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $850.3 million in Q1 2022 and bottomed at $218.1 million in Q3 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $485.6 million, with a median of $434.8 million recorded in 2024.
  • Peak annual rise in Liabilities and Shareholders Equity hit 4.75% in 2025, while the deepest fall reached 41.48% in 2025.
  • Kodiak Sciences' Liabilities and Shareholders Equity stood at $666.6 million in 2022, then decreased by 28.09% to $479.4 million in 2023, then fell by 30.0% to $335.6 million in 2024, then rose by 4.75% to $351.5 million in 2025, then decreased by 12.95% to $306.0 million in 2026.
  • Per Business Quant, the three most recent readings for KOD's Liabilities and Shareholders Equity are $306.0 million (Q1 2026), $351.5 million (Q4 2025), and $218.1 million (Q3 2025).